Aarey Drugs & Pharmaceuticals Limited (BOM:524412)

Market Cap	1.85B
Revenue (ttm)	4.74B
Net Income (ttm)	40.24M
Shares Out	27.95M
EPS (ttm)	1.43
PE Ratio	46.15
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,640
Average Volume	4,435
Open	67.30
Previous Close	67.30
Day's Range	65.56 - 68.74
52-Week Range	31.30 - 75.75
Beta	0.53
RSI	50.11
Earnings Date	Aug 14, 2025

About BOM:524412

Aarey Drugs & Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients, intermediates, and specialty chemicals for various industrial applications in India. The company provides mono methyl and die methyl urea, ortho para nitro anisole, 2 bromomethyl 1, and 3 dioxalane and uracile, as well as active pharma ingredients, such as metformin HCL, mefenamic acid, and doxophylline. It also offers chemicals and solvents, including aromatic chemicals, chemical acids, chlor alkalies, glycols and glycol ethers, fiber intermediates,...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1990
• Employees: 132
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524412

Financial Performance

In 2024, BOM:524412's revenue was 4.74 billion, an increase of 19.80% compared to the previous year's 3.96 billion. Earnings were 40.24 million, a decrease of -14.09%.